FUSIONQUANT
DEAD

Serial Number

78249512

Owner

IPSOGEN

Attorney

Barry L. Kelmachter

Filing Date

May 14, 2003

Add to watchlist:

No watchlists yet
View on USPTO

FUSIONQUANT Trademark

Serial Number: 78249512 • Registration: 2930568

FUSIONQUANT is a trademark filed by IPSOGEN on May 14, 2003. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

IPSOGEN (10 trademarks)

232 boulevard Sainte-Marguerite
F-13273 Marseille Cedex 09 , FR

Entity Type: 03

Trademark Details

Filing Date

May 14, 2003

Registration Date

March 8, 2005

Published for Opposition

December 14, 2004

Cancellation Date

October 9, 2015

Goods & Services

Diagnostic biological reagents for clinical or medical laboratory use or for determining gene translocations with partner genes which lead to neurological illness, muscular dystrophy, autism, schizophrenia, Down syndrome, leukemia, lymphoma, melanomas of soft parts, liposarcoma, Ewings sarcoma, neuroectodermal tumors, myelodysplastic syndromes, chondrosarcoma, desmoplastic small round cell tumor, rhabdomyosarcoma, non-Hodgkins lymphoma, myeloproliferative disorders, cogenital fibrosarcoma, nephromas, multiple myelomas, parathyroid ademnomes, parathyroid neoplasms, adenomas, lymphoproliferative disorders, plasma cell malignancies, Burkitt lymphoma, meningiomas, dermatofibrosarcoma protuberans, papillary carcinoma, cemento ossifying fibromas of the orbit, orbital neoplasms, ossifying fibromas, salivary gland neoplasms, pleomorphic adenomas, lipomas, hamartomas, uterine neoplasms, leiomyomas, osteosarcomas, cultured tumor cells, neuroblastomas, plasma cell granulomas, papillary renal cell carcinomas, kidney neoplasms, renal cell carcinomas, papillary carcinomas, follicular adenocarcinomas, endometrial neoplasms, follicular lymphomas, glioblastomas, splenic neoplasms, lung neoplasms, squamous cell carcinomas, giant cell fibroblastoma, Bednar tumors, giant cell carcinomas, skin neoplasms, lipoblastomas, ganglioneuroblastomas, breast neoplasms, hypereosinophilic syndrome, synovial sarcoma; pharmaceutical preparations for treatment of muscular dystrophy, autism, schizophrenia, Down syndrome, leukemia, lymphoma, melanomas of soft parts, liposarcoma, Ewings sarcoma, neuroectodermal tumors, myelodysplastic syndromes, chondrosarcoma, desmoplastic small round cell tumor, rhabdomyosarcoma, non-Hodgkins lymphoma, myeloproliferative disorders, cogenital fibrosarcoma, nephromas, multiple myelomas, parathyroid ademnomes, parathyroid neoplasms, adenomas, lymphoproliferative disorders, plasma cell malignancies, Burkitt lymphoma, meningiomas, dermatofibrosarcoma protuberans, papillary carcinoma, cemento ossifying fibromas of the orbit, orbital neoplasms, ossifying fibromas, salivary gland neoplasms, pleomorphic adenomas, lipomas, hamartomas, uterine neoplasms, leiomyomas, osteosarcomas, cultured tumor cells, neuroblastomas, plasma cell granulomas, papillary renal cell carcinomas, kidney neoplasms, renal cell carcinomas, papillary carcinomas, follicular adenocarcinomas, endometrial neoplasms, follicular lymphomas, glioblastomas, splenic neoplasms, lung neoplasms, squamous cell carcinomas, giant cell fibroblastoma, Bednar tumors, giant cell carcinomas, skin neoplasms, lipoblastomas, ganglioneuroblastomas, breast neoplasms, hypereosinophilic syndrome, synovial sarcoma

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Oct 9, 2015 CAEX
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Mar 21, 2011 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 18, 2011 APRE
TEAS SECTION 8 & 15 RECEIVED
Mar 3, 2011 E815
REGISTERED-PRINCIPAL REGISTER
Mar 8, 2005 R.PR
PUBLISHED FOR OPPOSITION
Dec 14, 2004 PUBO
NOTICE OF PUBLICATION
Nov 24, 2004 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 8, 2004 PREV
ASSIGNED TO LIE
Oct 6, 2004 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 30, 2004 CNSA
AMENDMENT FROM APPLICANT ENTERED
Sep 15, 2004 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 26, 2004 CRFA
Sec. 1(B) CLAIM DELETED
Aug 26, 2004 1.BD
PAPER RECEIVED
Aug 26, 2004 MAIL
LETTER OF SUSPENSION E-MAILED
Jun 23, 2004 GNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 28, 2004 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 28, 2004 CRFA
PAPER RECEIVED
May 28, 2004 MAIL
NON-FINAL ACTION MAILED
Dec 11, 2003 CNRT
ASSIGNED TO EXAMINER
Dec 4, 2003 DOCK
CASE FILE IN TICRS
Aug 13, 2003 CFIT
CASE FILE IN TICRS
Aug 13, 2003 CFIT
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jul 23, 2003 AMPX
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 23, 2003 CRFA
PAPER RECEIVED
Jul 23, 2003 MAIL